BRD4

Last updated
BRD4
Protein BRD4 PDB 2oss.png
Available structures
PDB Human UniProt search: PDBe RCSB
Identifiers
Aliases BRD4 , CAP, HUNK1, HUNKI, MCAP, bromodomain containing 4
External IDs OMIM: 608749 HomoloGene: 137685 GeneCards: BRD4
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_014299
NM_058243
NM_001330384
NM_001379291
NM_001379292

n/a

RefSeq (protein)

NP_001317313
NP_055114
NP_490597
NP_001366220
NP_001366221

n/a

Location (UCSC) Chr 19: 15.24 – 15.33 Mb n/a
PubMed search [2] n/a
Wikidata
View/Edit Human

Bromodomain-containing protein 4 is a protein that in humans is encoded by the BRD4 gene. [3] [4]

BRD4 is a member of the BET (bromodomain and extra terminal domain) family, which also includes BRD2, BRD3, and BRDT. [5] BRD4, similar to other BET family members, contains two bromodomains that recognize acetylated lysine residues. [6] BRD4 also has an extended C-terminal domain with little sequence homology to other BET family members. [5]

Structure

The two bromodomains in BRD4, termed BD1 and BD2, consist of 4 alpha-helices linked by 2 loops. [7] The ET domain structure is made up of 3 alpha-helices and a loop. [8] The C-terminal domain of BRD4 has been implicated in promoting gene transcription through interaction with the transcription elongation factor P-TEFb and RNA polymerase II. [9] [10] [11]

Function

The protein encoded by this gene is homologous to the murine protein MCAP, which associates with chromosomes during mitosis, and to the human BRD2 (RING3) protein, a serine/threonine kinase. Each of these proteins contains two bromodomains, a conserved sequence motif which may be involved in chromatin targeting. This gene has been implicated as the chromosome 19 target of translocation t(15;19)(q13;p13.1), which defines the NUT midline carcinoma. Two alternatively spliced transcript variants have been described. [4]

Role in cancer

Most cases of NUT midline carcinoma involve translocation of the BRD4 gene with NUT genes. [12] BRD4 is often required for expression of Myc and other "tumor driving" oncogenes in hematologic cancers including multiple myeloma, acute myelogenous leukemia and acute lymphoblastic leukaemia. [13]

BRD4 is a major target of BET inhibitors, [13] [14] a class of pharmaceutical drugs currently being evaluated in clinical trials.

Interactions

Notably, BRD4 interacts with P-TEFb via its P-TEFb interaction domain (PID), thereby stimulating its kinase activity and stimulating its phosphorylation of the carboxy-terminal domain (CTD) of RNA polymerase II. [15] Recent review. [16]

BRD4 has been shown to interact with GATA1, [17] JMJD6, [18] RFC2, [19] RFC3, [19] RFC1, [19] RFC4 [19] and RFC5. [19]

BRD4 has also been implicated in binding with the diacetylated Twist protein, and the disruption of this interaction has been shown to suppress tumorigenesis in basal-like breast cancer. [20]

BRD4 has also been shown to interact with a variety of inhibitors, such as MS417; inhibition of BRD4 with MS417 has been shown to down-regulate NF-κB activity seen in HIV-associated kidney disease. [21] BRD4 also interacts with apabetalone (RVX-208), [22] which is being evaluated for treatment of atherosclerosis and cardiovascular disease.

Related Research Articles

<i>Papillomaviridae</i> Family of viruses

Papillomaviridae is a family of non-enveloped DNA viruses whose members are known as papillomaviruses. Several hundred species of papillomaviruses, traditionally referred to as "types", have been identified infecting all carefully inspected mammals, but also other vertebrates such as birds, snakes, turtles and fish. Infection by most papillomavirus types, depending on the type, is either asymptomatic or causes small benign tumors, known as papillomas or warts. Papillomas caused by some types, however, such as human papillomaviruses 16 and 18, carry a risk of becoming cancerous.

Bookmarking refers to a potential mechanism of transmission of gene expression programs through cell division.

<span class="mw-page-title-main">Bromodomain</span>

A bromodomain is an approximately 110 amino acid protein domain that recognizes acetylated lysine residues, such as those on the N-terminal tails of histones. Bromodomains, as the "readers" of lysine acetylation, are responsible in transducing the signal carried by acetylated lysine residues and translating it into various normal or abnormal phenotypes. Their affinity is higher for regions where multiple acetylation sites exist in proximity. This recognition is often a prerequisite for protein-histone association and chromatin remodeling. The domain itself adopts an all-α protein fold, a bundle of four alpha helices each separated by loop regions of variable lengths that form a hydrophobic pocket that recognizes the acetyl lysine.

<span class="mw-page-title-main">P-TEFb</span>

The positive transcription elongation factor, P-TEFb, is a multiprotein complex that plays an essential role in the regulation of transcription by RNA polymerase II in eukaryotes. Immediately following initiation Pol II becomes trapped in promoter proximal paused positions on the majority of human genes. P-TEFb is a cyclin dependent kinase that can phosphorylate the DRB sensitivity inducing factor (DSIF) and negative elongation factor (NELF), as well as the carboxyl terminal domain of the large subunit of Pol II and this causes the transition into productive elongation leading to the synthesis of mRNAs. P-TEFb is regulated in part by a reversible association with the 7SK snRNP. Treatment of cells with the P-TEFb inhibitors DRB or flavopidirol leads to loss of mRNA production and ultimately cell death.

<span class="mw-page-title-main">7SK RNA</span> Small nuclear RNA found in metazoans

In molecular biology 7SK is an abundant small nuclear RNA found in metazoans. It plays a role in regulating transcription by controlling the positive transcription elongation factor P-TEFb. 7SK is found in a small nuclear ribonucleoprotein complex (snRNP) with a number of other proteins that regulate the stability and function of the complex.

<span class="mw-page-title-main">Cyclin-dependent kinase 9</span> Protein-coding gene in the species Homo sapiens

Cyclin-dependent kinase 9 or CDK9 is a cyclin-dependent kinase associated with P-TEFb.

<span class="mw-page-title-main">Cyclin T1</span> Protein-coding gene in humans

Cyclin-T1 is a protein that in humans is encoded by the CCNT1 gene.

<span class="mw-page-title-main">SUPT5H</span> Protein-coding gene in the species Homo sapiens

Transcription elongation factor SPT5 is a protein that in humans is encoded by the SUPT5H gene.

<span class="mw-page-title-main">IRF2</span> Protein-coding gene in the species Homo sapiens

Interferon regulatory factor 2 is a protein that in humans is encoded by the IRF2 gene.

<span class="mw-page-title-main">RFC1</span> Proteine

Replication factor C subunit 1 is a protein that in humans is encoded by the RFC1 gene.

<span class="mw-page-title-main">RFC4</span> Protein-coding gene in the species Homo sapiens

Replication factor C subunit 4 is a protein that in humans is encoded by the RFC4 gene.

<span class="mw-page-title-main">RFC2</span> Protein-coding gene in the species Homo sapiens

Replication factor C subunit 2 is a protein that in humans is encoded by the RFC2 gene.

<span class="mw-page-title-main">BRD2</span> Protein-coding gene in the species Homo sapiens

Bromodomain-containing protein 2 is a protein that in humans is encoded by the BRD2 gene. BRD2 is part of the Bromodomain and Extra-Terminal motif (BET) protein family that also contains BRD3, BRD4, and BRDT in mammals

<span class="mw-page-title-main">RFC3</span> Protein-coding gene in the species Homo sapiens

Replication factor C subunit 3 is a protein that in humans is encoded by the RFC3 gene.

<span class="mw-page-title-main">RFC5</span> Protein-coding gene in the species Homo sapiens

Replication factor C subunit 5 is a protein that in humans is encoded by the RFC5 gene.

<span class="mw-page-title-main">Cyclin T2</span> Protein-coding gene in the species Homo sapiens

Cyclin-T2 is a protein that in humans is encoded by the CCNT2 gene.

<span class="mw-page-title-main">Bromodomain-containing protein 3</span> Protein-coding gene in the species Homo sapiens

Bromodomain-containing protein 3 (BRD3) also known as RING3-like protein (RING3L) is a protein that in humans is encoded by the BRD3 gene. This gene was identified based on its homology to the gene encoding the RING3 (BRD2) protein, a serine/threonine kinase. The gene maps to 9q34, a region which contains several major histocompatibility complex (MHC) genes.

<span class="mw-page-title-main">Negative elongation factor</span> Protein

In molecular biology, the NELF is a four-subunit protein complex that negatively impacts transcription by RNA polymerase II by pausing about 20-60 nucleotides downstream from the transcription start site (TSS).

Epigenetics of human development is the study of how epigenetics effects human development.

<span class="mw-page-title-main">Transcriptional amplification</span>

In genetics, transcriptional amplification is the process in which the total amount of messenger RNA (mRNA) molecules from expressed genes is increased during disease, development, or in response to stimuli.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000141867 - Ensembl, May 2017
  2. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. Dey A, Ellenberg J, Farina A, Coleman AE, Maruyama T, Sciortino S, Lippincott-Schwartz J, Ozato K (Sep 2000). "A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition". Molecular and Cellular Biology. 20 (17): 6537–49. doi:10.1128/MCB.20.17.6537-6549.2000. PMC   86127 . PMID   10938129.
  4. 1 2 "Entrez Gene: BRD4 bromodomain containing 4".
  5. 1 2 Zeng L, Zhou MM (Feb 2002). "Bromodomain: an acetyl-lysine binding domain". FEBS Letters. 513 (1): 124–8. doi:10.1016/s0014-5793(01)03309-9. PMID   11911891. S2CID   29706103.
  6. Shi J, Vakoc CR (Jun 2014). "The mechanisms behind the therapeutic activity of BET bromodomain inhibition". Molecular Cell. 54 (5): 728–736. doi:10.1016/j.molcel.2014.05.016. PMC   4236231 . PMID   24905006.
  7. Devaiah BN, Singer DS (1 January 2013). "Two faces of brd4: mitotic bookmark and transcriptional lynchpin". Transcription. 4 (1): 13–17. doi:10.4161/trns.22542. PMC   3644036 . PMID   23131666.
  8. Wu SY, Chiang CM (May 2007). "The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation". The Journal of Biological Chemistry. 282 (18): 13141–5. doi: 10.1074/jbc.r700001200 . PMID   17329240.
  9. Itzen, F; Greifenberg, A. K.; Bösken, C. A.; Geyer, M (2014). "Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation". Nucleic Acids Research. 42 (12): 7577–90. doi:10.1093/nar/gku449. PMC   4081074 . PMID   24860166.
  10. Jonkers, I; Lis, J. T. (2015). "Getting up to speed with transcription elongation by RNA polymerase II". Nature Reviews Molecular Cell Biology. 16 (3): 167–77. doi:10.1038/nrm3953. PMC   4782187 . PMID   25693130.
  11. Yang, Z; Yik, J. H.; Chen, R; He, N; Jang, M. K.; Ozato, K; Zhou, Q (2005). "Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4". Molecular Cell. 19 (4): 535–45. doi: 10.1016/j.molcel.2005.06.029 . PMID   16109377.
  12. French CA (Jun 2010). "Demystified molecular pathology of NUT midline carcinomas". Journal of Clinical Pathology. 63 (6): 492–6. doi:10.1136/jcp.2007.052902. PMID   18552174. S2CID   2200842.
  13. 1 2 Da Costa, D.; Agathanggelou, A.; Perry, T.; Weston, V.; Petermann, E.; Zlatanou, A.; Oldreive, C.; Wei, W.; Stewart, G. (2013-07-19). "BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia". Blood Cancer Journal. 3 (7): e126. doi:10.1038/bcj.2013.24. PMC   3730202 . PMID   23872705.
  14. Shi J, Vakoc CR (Jun 2014). "The mechanisms behind the therapeutic activity of BET bromodomain inhibition". Molecular Cell. 54 (5): 728–36. doi:10.1016/j.molcel.2014.05.016. PMC   4236231 . PMID   24905006.
  15. Itzen F, Greifenberg AK, Bösken CA, Geyer M (Jul 2014). "Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation". Nucleic Acids Research. 42 (12): 7577–7590. doi:10.1093/nar/gku449. PMC   4081074 . PMID   24860166.
  16. Quaresma, AJ; Bugai A; Barboric M. (2016). "Cracking the control of RNA polymerase II elongation by 7SK snRNP and P-TEFb". Nucleic Acids Research. 44 (8): 7527–7539. doi:10.1093/nar/gkw585. PMC   5027500 . PMID   27369380.
  17. Lamonica JM, Deng W, Kadauke S, Campbell AE, Gamsjaeger R, Wang H, Cheng Y, Billin AN, Hardison RC, Mackay JP, Blobel GA (May 2011). "Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes". Proceedings of the National Academy of Sciences of the United States of America. 108 (22): E159–68. doi: 10.1073/pnas.1102140108 . PMC   3107332 . PMID   21536911.
  18. Liu W, Ma Q, Wong K, Li W, Ohgi K, Zhang J, Aggarwal AK, Rosenfeld MG (Dec 2013). "Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release". Cell. 155 (7): 1581–95. doi:10.1016/j.cell.2013.10.056. PMC   3886918 . PMID   24360279.
  19. 1 2 3 4 5 Maruyama T, Farina A, Dey A, Cheong J, Bermudez VP, Tamura T, Sciortino S, Shuman J, Hurwitz J, Ozato K (Sep 2002). "A Mammalian bromodomain protein, brd4, interacts with replication factor C and inhibits progression to S phase". Molecular and Cellular Biology. 22 (18): 6509–20. doi:10.1128/MCB.22.18.6509-6520.2002. PMC   135621 . PMID   12192049.
  20. Shi J, Wang Y, Zeng L, Wu Y, Deng J, Zhang Q, Lin Y, Li J, Kang T, Tao M, Rusinova E, Zhang G, Wang C, Zhu H, Yao J, Zeng YX, Evers BM, Zhou MM, Zhou BP (Feb 2014). "Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer". Cancer Cell. 25 (2): 210–225. doi:10.1016/j.ccr.2014.01.028. PMC   4004960 . PMID   24525235.
  21. Zhang G, Liu R, Zhong Y, Plotnikov AN, Zhang W, Zeng L, Rusinova E, Gerona-Nevarro G, Moshkina N, Joshua J, Chuang PY, Ohlmeyer M, He JC, Zhou MM (Aug 2012). "Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition". The Journal of Biological Chemistry. 287 (34): 28840–28851. doi: 10.1074/jbc.M112.359505 . PMC   3436579 . PMID   22645123.
  22. McLure KG, Gesner EM, Tsujikawa L, Kharenko OA, Attwell S, Campeau E, Wasiak S, Stein A, White A, Fontano E, Suto RK, Wong NC, Wagner GS, Hansen HC, Young PR (31 December 2013). "RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist". PLOS ONE. 8 (12): e83190. Bibcode:2013PLoSO...883190M. doi: 10.1371/journal.pone.0083190 . PMC   3877016 . PMID   24391744.

Further reading